BioMOBIUS™ Research Platform Allows Sophisticated Technology Solutions for Biomedical Research

TRIL (Technology Research for Independent Living) CentreTRIL (Technology Research for Independent Living) Centre launched the BioMOBIUS™ Research Platform, an open shareable technology platform, which allows researcher to rapidly develop sophisticated technology solutions for biomedical research. This platform helps researchers to reduce the time spent on developing foundational technologies, allowing them to focus on their actual research.

The software elements of BioMOBIUS™ provide:

  • Rapid Development (Graphical Development Environment)
  • Biosignal Processing Applications (Real Time)
  • Mobile hardware and physiological sensor support
  • Straightforward user interfaces (GUI Designer)
  • Reduced Development Replication (Re-use of Blocks)
  • Targeting applications

The BioMOBIUS Research Platform was developed by the TRIL Centre, a groundbreaking research collaboration between Intel Corporation and a number of Irish academic partners, and jointly funded by Intel and the Industrial Development Agency (IDA) Ireland. Its goal is to explore technology to help older people to continue living independently. The platform is being used primarily by TRIL researchers to help clinicians detect and prevent or alleviate certain conditions related to ageing, such as falls and cognitive decline, and to help older people to strengthen their social connections.

The hardware elements of the BioMOBIUS™ research platform provide support for the SHIMMER wireless sensor platform and other third party hardware and sensor devices.

BioMOBIUS™ is freely available to users for research purposes only. Please follow the links to the register and download pages to obtain a copy of the BioMOBIUS™ software environment. Details on hardware support and availability can be found in the hardware section. Please feel to share your experiences of MOBIUS and suggestions for enhancements and new features via the provided discussion forum.

For further information, please visit:
http://biomobius.trilcentre.org

Related news articles:

About the TRIL Centre
The TRIL Centre is a multi-million euro research collaboration between industry and academic partners including Intel, University College Dublin, Trinity College Dublin and the National University of Ireland, Galway. The Centre has created dedicated laboratories at Intel and in each of the universities involved, and is driving bi-directional knowledge and technology transfer of research that addresses the physical, cognitive and social consequences of ageing. The TRIL Centre is one of the largest research projects of its kind in the world. It will develop innovative technologies to help people 'age in place' wherever they choose to live. For more information, please visit www.trilcentre.org.

Most Popular Now

Accelerating NHS Digital Maturity: Paper…

Digitised clinical noting at South Tees Hospitals NHS Foundation Trust is creating efficiencies for busy doctors and nurses. The trust’s CCIO Dr Andrew Adair, deputy CCIO Dr John Greenaway, and...

AI Tool Helps Predict Who will Benefit f…

A study led by UCLA investigators shows that artificial intelligence (AI) could play a key role in improving treatment outcomes for men with prostate cancer by helping physicians determine who...

New Study Shows Promise for Gamified mHe…

A new study published in Multiple Sclerosis and Related Disorders highlights the potential of More Stamina, a gamified mobile health (mHealth) app designed to help people with Multiple Sclerosis (MS)...

Research Shows AI Technology Improves Pa…

Existing research indicates that the accuracy of a Parkinson's disease diagnosis hovers between 55% and 78% in the first five years of assessment. That's partly because Parkinson's sibling movement disorders...

AI in Healthcare: How do We Get from Hyp…

The Highland Marketing advisory board met to consider the government's enthusiasm for AI. To date, healthcare has mostly experimented with decision support tools, and their impact on the NHS and...

New AI Tool Accelerates Disease Treatmen…

University of Virginia School of Medicine scientists have created a computational tool to accelerate the development of new disease treatments. The tool goes beyond current artificial intelligence (AI) approaches by...

DMEA sparks: The Future of Digital Healt…

8 - 10 April 2025, Berlin, Germany. Digitalization is considered one of the key strategies for addressing the shortage of skilled workers - but the digital health sector also needs qualified...

First Therapy Chatbot Trial Shows AI can…

Dartmouth researchers conducted the first clinical trial of a therapy chatbot powered by generative AI and found that the software resulted in significant improvements in participants' symptoms, according to results...

Who's to Blame When AI Makes a Medi…

Assistive artificial intelligence technologies hold significant promise for transforming health care by aiding physicians in diagnosing, managing, and treating patients. However, the current trend of assistive AI implementation could actually...

DeepSeek: The "Watson" to Doct…

DeepSeek is an artificial intelligence (AI) platform built on deep learning and natural language processing (NLP) technologies. Its core products include the DeepSeek-R1 and DeepSeek-V3 models. Leveraging an efficient Mixture...

Stepping Hill Hospital Announced as SPAR…

Stepping Hill Hospital, part of Stockport NHS Foundation Trust, has replaced its bedside units with state-of-the art devices running a full range of information, engagement, communications and productivity apps, to...

DMEA 2025: Digital Health Worldwide in B…

8 - 10 April 2025, Berlin, Germany. From the AI Act, to the potential of the European Health Data Space, to the power of patient data in Scandinavia - DMEA 2025...